Table 2.
Characteristic (n = 1172a) | No. (%) or median [Q1;Q3] |
---|---|
Age, years | 66.0 [56.0;74.0] |
Sex | |
Male | 745 (63.6) |
Female | 427 (36.4) |
BMI, kg/m2, n = 1168 | 26.8 [24.0;31.1] |
APACHE II score at ICU admission, n = 1132 | 18.5 [13.0;26.0] |
SOFA score at ICU admission, n = 1042 | 7.0 [4.0;10.0] |
Number of comorbidities at ICU admission | 3.0 [1.0;5.0] |
Type of ICU admission | |
Non-surgical emergency | 573 (48.9) |
Surgical emergency | 360 (30.7) |
Surgical elective | 220 (18.8) |
Others | 19 (1.6) |
Main reason(s) for ICU admissionb | |
Respiratory | 546 (46.6) |
Infection | 362 (30.9) |
Cardiac | 343 (29.3) |
Hepatic/GI/digestive | 279 (23.8) |
Neurological | 134 (11.4) |
Renal | 126 (10.8) |
Trauma | 116 (9.9) |
Others | 74 (6.3) |
Sedationc | 885 (75.5) |
Sum of days on sedation, n = 885 | 5.0 [2.0;10.0] |
Vasopressorsc | 886 (75.6) |
Sum of days on vasopressors, n = 886 | 4.0 [2.0;8.0] |
Ventilatory supportc,d | 988 (84.3) |
Sum of days on ventilatory support, n = 988 | 7.0 [4.0;13.0] |
Invasive mechanical ventilation between day 1 to 3 of ICU admission | 813 (69.4) |
Physiotherapyc | 1006 (85.8) |
Sum of days on physiotherapy, n = 1006 | 7.0 [4.0;11.0] |
Healthcare-associated infections after day 3 of ICU admission | 230 (19.6) |
Days in ICU until first infection, n = 230 | 6.0 [4.0;9.0] |
Mobility status (IMS score) | 10.0 [8.0;10.0] |
before ICU admission, n = 1168 | 10.0 [8.0;10.0] |
At day 15, n = 1057 | 5.0 [1.0;10.0] |
At day 30, n = 949 | 9.0 [3.0;10.0] |
At day 90, n = 844 | 10.0 [9.0;10.0] |
ICU LOS, days, n = 1158 | 10.0 [7.0;16.0] |
Hospital LOS, days, n = 1077 | 23.0 [15.0;36.0] |
ICU mortality, n = 1082 | 168 (15.5) |
Hospital mortality, n = 1082 | 244 (22.6) |
90-day mortality, n = 1172 | 276 (23.5) |
APACHE acute physiology and chronic health evaluation, BMI body mass index, ICU intensive care unit, IMS ICU mobility scale, IQR interquartile range, LOS length of stay, SOFA Sequential Organ Failure Assessment
aUnless otherwise indicated
bMultiresponse variable
cOn at least one day during the first 15 observation days
dIncludes invasive, noninvasive ventilation and high flow nasal oxygen therapy